Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals
HM Al-Kuraishy, GES Batiha, H Faidah… - …, 2022 - Springer
Pirfenidone (PFN) is an anti-fibrotic drug with significant anti-inflammatory property used for
treatment of fibrotic conditions such as idiopathic pulmonary fibrosis (IPF). In the coronavirus …
treatment of fibrotic conditions such as idiopathic pulmonary fibrosis (IPF). In the coronavirus …
A potential link between visceral obesity and risk of Alzheimer's disease
Alzheimer's disease (AD) is the most common type of dementia characterized by the
deposition of amyloid beta (Aβ) plaques and tau-neurofibrillary tangles in the brain. Visceral …
deposition of amyloid beta (Aβ) plaques and tau-neurofibrillary tangles in the brain. Visceral …
Statins use in Alzheimer disease: bane or boon from frantic search and narrative review
Alzheimer's disease (AD) was used to describe pre-senile dementia to differentiate it from
senile dementia, which develops in the adult age group of more than 65 years. AD is …
senile dementia, which develops in the adult age group of more than 65 years. AD is …
The potential role of growth differentiation factor 15 in COVID-19: a corollary subjective effect or not?
Coronavirus disease 2019 (COVID-19) is primarily caused by various forms of severe acute
respiratory syndrome coronavirus type 2 (SARS-CoV-2) variants. COVID-19 is characterized …
respiratory syndrome coronavirus type 2 (SARS-CoV-2) variants. COVID-19 is characterized …
Montelukast and acute coronary syndrome: the endowed drug
BM Alomair, HM Al-Kuraishy, AI Al-Gareeb… - Pharmaceuticals, 2022 - mdpi.com
Acute coronary syndrome (ACS) is a set of signs and symptoms caused by a reduction of
coronary blood flow with subsequent myocardial ischemia. ACS is associated with activation …
coronary blood flow with subsequent myocardial ischemia. ACS is associated with activation …
The potential therapeutic effect of phosphodiesterase 5 inhibitors in the acute ischemic stroke (AIS)
R AlRuwaili, HM Al-Kuraishy, M Alruwaili… - Molecular and Cellular …, 2023 - Springer
Acute ischemic stroke (AIS) is a focal neurological disorder that accounts for 85% of all
stroke types, due to occlusion of cerebral arteries by thrombosis and emboli. AIS is also …
stroke types, due to occlusion of cerebral arteries by thrombosis and emboli. AIS is also …
[HTML][HTML] SARS-CoV-2 infection and dysregulation of nuclear factor erythroid-2-related factor 2 (Nrf2) pathway
Abstract Coronavirus disease 2019 (COVID-19) is a recent pandemic caused by a novel
severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) leading to pulmonary and …
severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) leading to pulmonary and …
Pregnancy and COVID-19: high or low risk of vertical transmission
HM Al-Kuraishy, AI Al-Gareeb, NKA Albezrah… - Clinical and …, 2023 - Springer
Abstract Coronavirus disease 19 (COVID-19) is an infectious disease caused by severe
acute respiratory syndrome 2 (SARS-CoV-2). Throughout the pandemic, evidence on the …
acute respiratory syndrome 2 (SARS-CoV-2). Throughout the pandemic, evidence on the …
Promising hepatoprotective agents from the natural sources: a study of scientific evidence
Background Natural bioactive components derived from plant secondary metabolites have
been pronounced as valuable alternatives for anticipating and subsiding hepatotoxic effects …
been pronounced as valuable alternatives for anticipating and subsiding hepatotoxic effects …
Roxadustat for SARS-CoV-2 infection: old signaling raised new hopes
L Alkazmi, HM Al-Kuraishy, GES Batiha… - Drugs in R&D, 2022 - Springer
Roxadustat (RXT)(4-hydroxyl-1-methyl-7-phenoxyisoquinoline-3-caboxylic acid)(Fig. 1) is
an orally active prolyl hydroxylase (PHD) inhibitor that increases production of endogenous …
an orally active prolyl hydroxylase (PHD) inhibitor that increases production of endogenous …